Advanced Biomed (ADVB) Prices 1.64M Share IPO at $4/sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/24/2026
- Wall St slips as Middle East escalations lifts oil; Trump-Xi talks in focus
- Oracle triggers force majeure on massive 'Project Jupiter' data center
- Oil gains on little sign of progress in US-Iran talks
- S&P 500 history shows strong gains across Fed hiking cycles: BCA
- JPMorgan upgrades CoreWeave on stronger compute pricing
- Bloom Energy falls as Oracle invokes force majeure on AI project
- Plug Power COO resigns to join another company
- Oracle triggers force majeure on massive 'Project Jupiter' data center
- Oracle Sends Force Majeure Notice Over New Mexico Data Center - Bloomberg
- Wall Street ends down as oil prices, Treasury yields rise
Advanced Biomed Inc. Announces Pricing of Initial Public Offering
March 6, 2025 9:02 AM ESTTainan, Taiwan, March 06, 2025 (GLOBE NEWSWIRE) -- Advanced Biomed Inc. (the Company or Advanced Biomed), a biotechnology company focused on early screening and detection, diagnosis and staging, and treatment of cancer, today announced the pricing of its initial public offering (the Offering) of 1,640,000 shares of common stock (Common Stock) at a public offering price of $4.00 per share. The shares of Common Stock have been approved for listing on the Nasdaq Capital Market and are expected to commence trading on March 6, 2025 under the ticker symbol ADVB.
The Company expects to receive aggregate gross proceeds of US$6.56 million from the Offering,... More
